Last reviewed · How we verify
Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice
The primary objective of this study is to compare the medication adherence measured by PDC of patients with FDC or double-pill combination therapy in real-world Japanese therapeutic practice.The further objective of this study is how much influence the background of patients to the adherence.
Details
| Lead sponsor | Boehringer Ingelheim |
|---|---|
| Status | WITHDRAWN |
| Start date | Wed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Hypertension
Interventions
- subjects treated with telmisartan/hydrochlorothiazide
- Subjects treated with Telmisartan and amlodipine
- subjects treated with Telmisartan+hydrochlorothiazide double-pill combination group
- subjects treated with telmisartan+amlodipine double pill
Countries
Japan